Transcriptional Profiling of Normal, Stenotic, and Regurgitant Human Aortic Valves
- PMID: 32674273
- PMCID: PMC7397246
- DOI: 10.3390/genes11070789
Transcriptional Profiling of Normal, Stenotic, and Regurgitant Human Aortic Valves
Abstract
The genetic mechanisms underlying aortic stenosis (AS) and aortic insufficiency (AI) disease progression remain unclear. We hypothesized that normal aortic valves and those with AS or AI all exhibit unique transcriptional profiles. Normal control (NC) aortic valves were collected from non-matched donor hearts that were otherwise acceptable for transplantation (n = 5). Valves with AS or AI (n = 5, each) were collected from patients undergoing surgical aortic valve replacement. High-throughput sequencing of total RNA revealed 6438 differentially expressed genes (DEGs) for AS vs. NC, 4994 DEGs for AI vs. NC, and 2771 DEGs for AS vs. AI. Among 21 DEGs of interest, APCDD1L, CDH6, COL10A1, HBB, IBSP, KRT14, PLEKHS1, PRSS35, and TDO2 were upregulated in both AS and AI compared to NC, whereas ALDH1L1, EPHB1, GPX3, HIF3A, and KCNT1 were downregulated in both AS and AI (p < 0.05). COL11A1, H19, HIF1A, KCNJ6, PRND, and SPP1 were upregulated only in AS, and NPY was downregulated only in AS (p < 0.05). The functional network for AS clustered around ion regulation, immune regulation, and lipid homeostasis, and that for AI clustered around ERK1/2 regulation. Overall, we report transcriptional profiling data for normal human aortic valves from non-matched donor hearts that were acceptable for transplantation and demonstrated that valves with AS and AI possess unique genetic signatures. These data create a roadmap for the development of novel therapeutics to treat AS and AI.
Keywords: RNA sequencing; aortic insufficiency; aortic stenosis; transcriptional profiling.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures






References
-
- Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., das Sandeep R., et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e526–e528. doi: 10.1161/CIR.0000000000000659. - DOI - PubMed
-
- Baumgartner H., Falk V., Bax J.J., de Bonis M., Hamm C., Holm P.J., Iung B., Lancellotti P., Lansac E., Muñoz D.R., et al. ESC Scientific Document Group 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2017;38:2739–2791. doi: 10.1093/eurheartj/ehx391. - DOI - PubMed
-
- Yadgir S., Johnson C.O., Aboyans V., Adebayo O.M., Adedoyin R.A., Afarideh M., Alahdab F., Alashi A., Alipour V., Arabloo J., et al. Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017. Circulation. 2020;141:1670–1680. doi: 10.1161/CIRCULATIONAHA.119.043391. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous